It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Neutrophils are the most abundant type of white blood cells in humans with biological roles relevant to inflammation, and fighting off infections. Neutrophil Extracellular Traps (NETs) act as enxogenous agents controlling invasion by bacteria, viruses, fungi, metabolic, and traumatic agents. Traditionally, studies have focused on elucidating molecular and cellular pathways preceding NET formation. Here, we developed a model to decode the human genome and proteome of developted NETs. Via in vitro system to differentiate HL-60 human myeloid cell line into neutrophil extracellular trap (ecTrap) producing cells, we isolated and captured ectrap derived DNA and proteins for shotgun sequencing. The genomic sequences revealed accurate delineation of gene composition including immune response genes and mitochondrial enrichment, while providing a reference database for future interrogation. Shotgun proteomics showed global proteins in differentiated cells with specific immune pathways when compared to undifferentiated counterparts. Coupled with omics’ approaches, we validated our system by functional assays and began to dissect host-microbial interactions. Our work provides a new understanding of the genomic and proteomic sequences, establishing the first human database deposition of neutrophil extracellular traps.
Measurement(s) | Genome Sequence Reads • Protein Abundance |
Technology Type(s) | Illuminia • liquid chromatography-tandem mass spectrometry |
Factor Type(s) | Neutrophil extracellular trap genome sequence • Neutrophil extracellular trap protein abundance |
Sample Characteristic - Organism | Homo sapiens |
Sample Characteristic - Environment | cell culture |
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 J. Craig Venter Institute, Department of Genomic Medicine and Infectious Diseases, La Jolla, USA (GRID:grid.469946.0)
2 J. Craig Venter Institute, Department of Infectious Diseases, Rockville, USA (GRID:grid.469946.0); National Center for Advancing Translational Sciences, Rockville, USA (GRID:grid.429651.d) (ISNI:0000 0004 3497 6087)
3 J. Craig Venter Institute, Department of Infectious Diseases, Rockville, USA (GRID:grid.469946.0); University of Delaware, Department of Chemistry and Biochemistry, Newark, USA (GRID:grid.33489.35) (ISNI:0000 0001 0454 4791)
4 J. Craig Venter Institute, Department of Genomic Medicine and Infectious Diseases, La Jolla, USA (GRID:grid.469946.0); University California San Diego, Division of Infectious Diseases and Global Public Health, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)